Thalidomide for the Treatment of Esophageal Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection

Autor: David A. Wohl, John L. Fahey, Miriam Chernoff, Nesli Basgoz, Albert W. Wu, Cecilia M. Shikuma, Laurie A. MacPhail, Thomas M. Hooton, Beverly E. Sha, David M. Simpson, Jeffrey M. Jacobson, Lawrence Fox, Carol B. Trapnell, John Spritzler, J. Brooks Jackson
Rok vydání: 1999
Předmět:
Zdroj: The Journal of Infectious Diseases. 180:61-67
ISSN: 1537-6613
0022-1899
DOI: 10.1086/314834
Popis: Background In patients with advanced human immunodeficiency virus (HIV) infection, aphthous ulceration of the mouth and oropharynx can become extensive and debilitating. Preliminary reports suggest that thalidomide may promote the healing of oral aphthous ulcers. Methods We performed a double-blind, randomized, placebo-controlled study of thalidomide as therapy for oral aphthous ulcers in HIV-infected patients. The patients received a four-week course of either 200 mg of thalidomide or placebo orally once per day. They were evaluated weekly for the condition of the ulcers, their quality of life, and evidence of toxicity. Assays were performed for plasma tumor necrosis factor α (TNF-α), soluble TNF-α receptors, and HIV RNA. Results Sixteen of 29 patients in the thalidomide group (55 percent) had complete healing of their aphthous ulcers after four weeks, as compared with only 2 of 28 patients in the placebo group (7 percent; odds ratio, 15; 95 percent confidence interval after adjustment for group sequenti...
Databáze: OpenAIRE